Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03664895` - Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)	Phase 3
Recruiting	`NCT05505357` - Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)	N/A
Completed	`NCT03669705` - No Axillary Surgery for Early Breast Cancer.
Terminated	`NCT05012397` - Milademetan in Advanced/Metastatic Solid Tumors	Phase 2
Recruiting	`NCT05877859` - Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Active, not recruiting	`NCT04398914` - Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer	Phase 2
Recruiting	`NCT05351424` - AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc	N/A
Active, not recruiting	`NCT03627988` - Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.	Phase 2
Completed	`NCT05300412` - The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer
Recruiting	`NCT04999917` - Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer	N/A
Completed	`NCT05019989` - Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study	N/A
Recruiting	`NCT06144944` - Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer	Phase 3
Recruiting	`NCT04891068` - BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer	Phase 2
Recruiting	`NCT05939310` - Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study	N/A
Not yet recruiting	`NCT06268665` - Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy	Phase 2
Completed	`NCT05463276` - The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
Completed	`NCT04729647` - Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer	N/A
Active, not recruiting	`NCT06234488` - Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
Recruiting	`NCT00437879` - Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.
Recruiting	`NCT05020860` - Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer	Phase 2

NCT number	NCT05910398
Study type	Interventional
Source	RenJi Hospital
Contact	Wenjin Yin, M.D.
Phone	86(21)58852345
Email	yinwenjin@renji.com
Status	Recruiting
Phase	Phase 3
Start date	June 1, 2023
Completion date	August 2030

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer — CORINNE-PI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms